NHS Wales has signed a memorandum of understanding (MoU) with Illumina to expand an earlier partnership focusing on lung ...

Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...

Overall, the quarter demonstrated Illumina's resilience in a constrained economic environment. Illumina is a prominent entity ...

Illumina, Inc. (NASDAQ:ILMN), a leader in DNA sequencing and array-based technologies, finds itself at a critical juncture as it navigates a rapidly evolving market landscape. The company's recent ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Shares of Illumina (ILMN) fell 6% post-market Monday after the company lowered its fiscal 2024 revenue guidance. Read more ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...

Illumina, Inc. today announced that its executives will be speaking at the following investor conferences: Wolfe Research ...

パズドラにおけるイルミナとロミアのアルバムの評価と使い道、ステータスを紹介しています。 2ターンの間、4コンボ加算。2ターンの間、属性吸収を無効化する。 (15→10ターン) スキルがそこそこ使える イルミナとロミアのアルバムはスキルがそこそこ ...